Corrigendum to - Chitosan modified 5-fluorouracil nanostructured lipid carriers for treatment of diabetic retinopathy in rats: A new dimension to an anticancer drug, Vol. 224, 1 January 2023, Pages 810-830
Deep Shikha Sharma(Lovely Professional University), Sachin Kumar Singh(Lovely Professional University), Sumant Saini(Panjab University), Bimlesh Kumar(Lovely Professional University), Monica Gulati(Lovely Professional University), Nitin Chitranshi(Macquarie University), Vivek Gupta(Edith Cowan University), Kamal Dua(University of Technology Sydney), Sukriti Vishwas(Lovely Professional University), Sharif Alhajlah(Shaqra University), Shaik Rahana Parveen(Lovely Professional University), Mohammed Alrouji(Shaqra University), Dinesh Kumar Chellappan(Ajman University), Sheetu Wadhwa(Lovely Professional University), Othman AlOmeir(Shaqra University), Andrew Morris(Swansea University), Gaurav Gupta(Gyan Vihar University), Flavia C. Zacconi(Pontificia Universidad Católica de Chile), Raimar Löebenberg(University of Alberta), Rubiya Khursheed(Lovely Professional University)
Cited by 0
Related Papers
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|373
Treatment strategies against diabetes: Success so far and challenges ahead
|European Journal of Pharmacology|2019|239
Nanocarriers in Ocular Drug Delivery: An Update Review
|Current Pharmaceutical Design|2009|195
The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress
|Drug Development Research|2019|181
Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes
|Frontiers in Immunology|2023|179